Corresponding Author: Alex H. Krist, MD, MPH, Virginia Commonwealth University, One Capitol Square, 6th Flr, 830 E Main St, Richmond, Virginia 23219 (chair@uspstf.ne)).
Accepted for Publication: December 4, 2020.
The US Preventive Services Task Force (USPSTF) members: Alex H. Krist, MD, MPH; Karina W. Davidson, PhD, MAS; Carol M. Mangione, MD, MSPH; Michael J. Barry, MD; Michael Cabana, MD, MA, MPH; Aaron B. Caughey, MD, PhD; Katrina Donahue, MD, MPH; Chyke A. Doubeni, MD, MPH; John W. Epling Jr, MD, MSEd; Martha Kubik, PhD, RN; Gbenga Ogedegbe, MD, MPH; Lori Pbert, PhD; Michael Silverstein, MD, MPH; Melissa A. Simon, MD, MPH; Chien-Wen Tseng, MD, MPH, MSEE; John B. Wong, MD.
Affiliations of The US Preventive Services Task Force (USPSTF) members: Fairfax Family Practice Residency, Fairfax, Virginia (Krist); Virginia Commonwealth University, Richmond (Krist); Feinstein Institute for Medical Research at Northwell Health, Manhasset, New York (Davidson); University of California, Los Angeles (Mangione); Harvard Medical School, Boston, Massachusetts (Barry); University of California, San Francisco (Cabana); Oregon Health & Science University, Portland (Caughey); University of North Carolina at Chapel Hill (Donahue); Mayo Clinic, Rochester, Minnesota (Doubeni); Virginia Tech Carilion School of Medicine, Roanoke (Epling Jr); George Mason University, Fairfax, Virginia (Kubik); New York University, New York, New York (Ogedegbe); University of Massachusetts Medical School, Worcester (Pbert); Boston University, Boston, Massachusetts (Silverstein); Northwestern University, Evanston, Illinois (Simon); University of Hawaii, Honolulu (Tseng); Pacific Health Research and Education Institute, Honolulu, Hawaii (Tseng); Tufts University School of Medicine, Boston, Massachusetts (Wong).
Author Contributions: Dr Krist had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The USPSTF members contributed equally to the recommendation statement.
Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Authors followed the policy regarding conflicts of interest described at https://www.uspreventiveservicestaskforce.org/Page/Name/conflict-of-interest-disclosures. All members of the USPSTF receive travel reimbursement and an honorarium for participating in USPSTF meetings. Dr Barry reported receiving grants and personal fees from Healthwise.
Funding/Support: The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.
Role of the Funder/Sponsor: AHRQ staff assisted in the following: development and review of the research plan, commission of the systematic evidence review from an Evidence-based Practice Center, coordination of expert review and public comment of the draft evidence report and draft recommendation statement, and the writing and preparation of the final recommendation statement and its submission for publication. AHRQ staff had no role in the approval of the final recommendation statement or the decision to submit for publication.
Disclaimer: Recommendations made by the USPSTF are independent of the US government. They should not be construed as an official position of AHRQ or the US Department of Health and Human Services.
Additional Contributions: We thank Tina Fan, MD, MPH (AHRQ), who contributed to the writing of the manuscript, and Lisa Nicolella, MA (AHRQ), who assisted with coordination and editing.
Additional Information: The US Preventive Services Task Force (USPSTF) makes recommendations about the effectiveness of specific preventive care services for patients without obvious related signs or symptoms. It bases its recommendations on the evidence of both the benefits and harms of the service and an assessment of the balance. The USPSTF does not consider the costs of providing a service in this assessment. The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision-making to the specific patient or situation. Similarly, the USPSTF notes that policy and coverage decisions involve considerations in addition to the evidence of clinical benefits and harms.
1. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. US Dept of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
2. Women and Smoking: A Report of the Surgeon General. US Dept of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2001.
3. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. US Dept of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2010.
4. WHO Recommendations for the Prevention and Management of Tobacco Use and Second-Hand Smoke Exposure in Pregnancy. World Health Organization; 2013.
6.Drake
P , Driscoll
AK , Mathews
TJ . Cigarette smoking during pregnancy: United States, 2016.
NCHS Data Brief. 2018;(305):1-8.
PubMedGoogle Scholar 9.Owens
DK , Davidson
KW , Krist
AH ,
et al; US Preventive Services Task Force. Primary care interventions for prevention and cessation of tobacco use in children and adolescents: US Preventive Services Task Force recommendation statement.
JAMA. 2020;323(16):1590-1598. doi:
10.1001/jama.2020.4679PubMedGoogle ScholarCrossref 12.Tobacco Use and Dependence Guideline Panel. Treating Tobacco Use and Dependence: 2008 Update: Clinical Practice Guideline. US Dept of Health and Human Services, Public Health Service; 2008.
13.Patnode
CD , Henderson
JT , Melknikow
J , Coppola
EL , Durbin
S , Thomas
R . Interventions for Tobacco Cessation in Adults, Including Pregnant Women: An Evidence Update for the U.S. Preventive Services Task Force. Evidence Synthesis No. 196. Agency for Healthcare Research and Quality; 2021. AHRQ publication 20-05264-EF-1.
14.Patnode
CD , Henderson
JT , Melknikow
J , Coppola
EL , Durbin
S , Thomas
R . Interventions for tobacco cessation in adults, including pregnant women: updated evidence report and systematic review for the US Preventive Services Task Force.
JAMA. Published January 19, 2021. doi:
10.1001/jama.2020.23541Google Scholar 16.Orleans
CT , Rimer
BK , Fleisher
L . Clear Horizons: A Quit Smoking Guide Especially for Those 50 and Over. Fox Chase Cancer Center; 1989.
17.Canga
N , De Irala
J , Vara
E , Duaso
MJ , Ferrer
A , Martínez-González
MA . Intervention study for smoking cessation in diabetic patients: a randomized controlled trial in both clinical and primary care settings.
Diabetes Care. 2000;23(10):1455-1460. doi:
10.2337/diacare.23.10.1455PubMedGoogle ScholarCrossref 18.Glynn
TJ , Manley
MW . How to Help Your Patients Stop Smoking: A National Cancer Institute Manual for Physicians. US Dept of Health and Human Services; 1998.
21. Clearing the Air: How to Quit Smoking and Quit for Keeps. National Cancer Institute; 1987.
24.Bock
B , Heron
K , Jennings
E ,
et al. A text message delivered smoking cessation intervention: the initial trial of TXT-2-Quit: randomized controlled trial.
JMIR Mhealth Uhealth. 2013;1(2):e17. doi:
10.2196/mhealth.2522PubMedGoogle Scholar 27. A Lifetime of Freedom From Smoking. American Lung Association; 1980.
28.McBride
CM , Scholes
D , Grothaus
LC , Curry
SJ , Ludman
E , Albright
J . Evaluation of a minimal self-help smoking cessation intervention following cervical cancer screening.
Prev Med. 1999;29(2):133-138. doi:
10.1006/pmed.1999.0514PubMedGoogle ScholarCrossref 29.Curry
SJ , McBride
C , Grothaus
LC , Louie
D , Wagner
EH . A randomized trial of self-help materials, personalized feedback, and telephone counseling with nonvolunteer smokers.
J Consult Clin Psychol. 1995;63(6):1005-1014. doi:
10.1037/0022-006X.63.6.1005PubMedGoogle ScholarCrossref 33.Solomon
L , Quinn
V . Spontaneous quitting: self-initiated smoking cessation in early pregnancy.
Nicotine Tob Res. 2004;6(suppl):S203-S216.
Google ScholarCrossref 34.Windsor
R , Woodby
L , Miller
T , Hardin
M . Effectiveness of Smoking Cessation and Reduction in Pregnancy Treatment (SCRIPT) methods in Medicaid-supported prenatal care: trial III.
Health Educ Behav. 2011;38(4):412-422. doi:
10.1177/1090198110382503PubMedGoogle ScholarCrossref 35.Fiore
MB , Bailey
WC , Cohen
S ,
et al. Smoking Cessation: Clinical Practice Guideline No. 18. Agency for Health Care Policy and Research; 1996.
38.Windsor
R , Crawford
M , Woodby
L . Commit to Quit Smoking During and After Pregnancy. DVD. Society for Public Health Education: 1998; edited 2004.
39.Windsor
R. A Pregnant Woman’s Guide to Quit Smoking. Society for Public Health Education; 2005.
41.Bullock
L , Everett
KD , Mullen
PD , Geden
E , Longo
DR , Madsen
R . Baby BEEP: a randomized controlled trial of nurses’ individualized social support for poor rural pregnant smokers.
Matern Child Health J. 2009;13(3):395-406. doi:
10.1007/s10995-008-0363-zPubMedGoogle ScholarCrossref 44.Stotts
AL , Groff
JY , Velasquez
MM ,
et al. Ultrasound feedback and motivational interviewing targeting smoking cessation in the second and third trimesters of pregnancy.
Nicotine Tob Res. 2009;11(8):961-968. doi:
10.1093/ntr/ntp095PubMedGoogle ScholarCrossref 45.Hoffmann
TC , Glasziou
PP , Boutron
I ,
et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide.
BMJ. 2014;348:g1687. doi:
10.1136/bmj.g1687PubMedGoogle ScholarCrossref 47. Smoking Cessation. A Report of the Surgeon General. Dept of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2020.
51.Nickels
AS , Warner
DO , Jenkins
SM , Tilburt
J , Hays
JT . Beliefs, practices, and self-efficacy of US physicians regarding smoking cessation and electronic cigarettes: a national survey.
Nicotine Tob Res. 2017;19(2):197-207. doi:
10.1093/ntr/ntw194PubMedGoogle ScholarCrossref 52.National Academies of Sciences, Engineering, and Medicine. Public Health Consequences of E-Cigarettes. National Academies Press; 2018.
55.Siu
AL ; US Preventive Services Task Force. Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U.S. Preventive Services Task Force recommendation statement.
Ann Intern Med. 2015;163(8):622-634. doi:
10.7326/M15-2023PubMedGoogle ScholarCrossref 56.Stead
LF , Buitrago
D , Preciado
N , Sanchez
G , Hartmann-Boyce
J , Lancaster
T . Physician advice for smoking cessation.
Cochrane Database Syst Rev. 2013;5(5):CD000165.
PubMedGoogle Scholar 57.Rice
VH , Heath
L , Livingstone-Banks
J , Hartmann-Boyce
J . Nursing interventions for smoking cessation.
Cochrane Database Syst Rev. 2017;12(12):CD001188.
PubMedGoogle Scholar 58.Lancaster
T , Stead
LF . Individual behavioural counselling for smoking cessation.
Cochrane Database Syst Rev. 2017;3(3):CD001292.
PubMedGoogle Scholar 60.Matkin
W , Ordóñez-Mena
JM , Hartmann-Boyce
J . Telephone counselling for smoking cessation.
Cochrane Database Syst Rev. 2019;5(5):CD002850.
PubMedGoogle Scholar 63.Lindson
N , Chepkin
SC , Ye
W , Fanshawe
TR , Bullen
C , Hartmann-Boyce
J . Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.
Cochrane Database Syst Rev. 2019;4(4):CD013308. doi:
10.1002/14651858.CD013308PubMedGoogle Scholar 64.Howes
S , Hartmann-Boyce
J , Livingstone-Banks
J , Hong
B , Lindson
N . Antidepressants for smoking cessation.
Cochrane Database Syst Rev. 2020;4(4):CD000031.
PubMedGoogle Scholar 67.Hartmann-Boyce
J , Hong
B , Livingstone-Banks
J , Wheat
H , Fanshawe
TR . Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation.
Cochrane Database Syst Rev. 2019;6(6):CD009670. doi:
10.1002/14651858.CD009670.pub4PubMedGoogle Scholar 71.Mirbolouk
M , Charkhchi
P , Kianoush
S ,
et al. Prevalence and distribution of e-cigarette use among U.S. adults: Behavioral Risk Factor Surveillance System, 2016.
Ann Intern Med. 2018;169(7):429-438. doi:
10.7326/M17-3440PubMedGoogle ScholarCrossref 76.O’Brien
B , Knight-West
O , Walker
N , Parag
V , Bullen
C . E-cigarettes versus NRT for smoking reduction or cessation in people with mental illness: secondary analysis of data from the ASCEND trial.
Tob Induc Dis. 2015;13(1):5. doi:
10.1186/s12971-015-0030-2PubMedGoogle ScholarCrossref 77.Caponnetto
P , Campagna
D , Cibella
F ,
et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study.
PLoS One. 2013;8(6):e66317. doi:
10.1371/journal.pone.0066317PubMedGoogle Scholar 79.Walker
N , Parag
V , Verbiest
M , Laking
G , Laugesen
M , Bullen
C . Nicotine patches used in combination with e-cigarettes (with and without nicotine) for smoking cessation: a pragmatic, randomised trial.
Lancet Respir Med. 2020;8(1):54-64. doi:
10.1016/S2213-2600(19)30269-3PubMedGoogle ScholarCrossref 81.Mills
EJ , Wu
P , Lockhart
I , Wilson
K , Ebbert
JO . Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation: a systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals.
Tob Induc Dis. 2010;8:8. doi:
10.1186/1617-9625-8-8PubMedGoogle ScholarCrossref 83.Hughes
JR , Stead
LF , Hartmann-Boyce
J , Cahill
K , Lancaster
T . Antidepressants for smoking cessation.
Cochrane Database Syst Rev. 2014;1(1):CD000031.
PubMedGoogle Scholar 84.Anthenelli
RM , Benowitz
NL , West
R ,
et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.
Lancet. 2016;387(10037):2507-2520. doi:
10.1016/S0140-6736(16)30272-0PubMedGoogle ScholarCrossref 89.Blount
BC , Karwowski
MP , Shields
PG ,
et al; Lung Injury Response Laboratory Working Group. Vitamin E acetate in bronchoalveolar-lavage fluid associated with EVALI.
N Engl J Med. 2020;382(8):697-705. doi:
10.1056/NEJMoa1916433PubMedGoogle ScholarCrossref 93.Larzelere
MM , Williams
DE . Promoting smoking cessation.
Am Fam Physician. 2012;85(6):591-598.
PubMedGoogle Scholar 100.Bhatnagar
A , Whitsel
LP , Ribisl
KM ,
et al; American Heart Association Advocacy Coordinating Committee, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Quality of Care and Outcomes Research. Electronic cigarettes: a policy statement from the American Heart Association.
Circulation. 2014;130(16):1418-1436. doi:
10.1161/CIR.0000000000000107PubMedGoogle ScholarCrossref